Home / Inspections / 1230610

FDA Inspection 1230610 — Baxter Healthcare Corporation

Baxter Healthcare Corporation — FEI 1417572

The FDA completed an inspection of Baxter Healthcare Corporation on February 6, 2024 in Deerfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 6, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Deerfield, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1171501 (VAI Thu Jun 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067768 (NAI Wed Aug 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988263 (VAI Wed Sep 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 921291 (NAI Fri Apr 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 827281 (NAI Fri Apr 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources